Published in Thromb Haemost on April 01, 2005
Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke. Nat Med (2008) 3.64
Proteome-based plasma markers of brain amyloid-β deposition in non-demented older individuals. J Alzheimers Dis (2010) 1.73
The role of reconsolidation and the dynamic process of long-term memory formation and storage. Front Behav Neurosci (2011) 1.28
Tissue-type plasminogen activator requires a co-receptor to enhance NMDA receptor function. J Neurochem (2008) 1.21
Brain extracellular matrix in neurodegeneration. Brain Pathol (2008) 1.15
Experimental models, neurovascular mechanisms and translational issues in stroke research. Br J Pharmacol (2007) 1.14
Enhanced clearance of Abeta in brain by sustaining the plasmin proteolysis cascade. Proc Natl Acad Sci U S A (2008) 1.12
Plasmin potentiates synaptic N-methyl-D-aspartate receptor function in hippocampal neurons through activation of protease-activated receptor-1. J Biol Chem (2008) 1.09
Deleterious effects of plasminogen activators in neonatal cerebral hypoxia-ischemia. Am J Pathol (2008) 1.01
Lithium inhibits Smad3/4 transactivation via increased CREB activity induced by enhanced PKA and AKT signaling. Mol Cell Neurosci (2007) 0.98
Plasmin-dependent modulation of the blood-brain barrier: a major consideration during tPA-induced thrombolysis? J Cereb Blood Flow Metab (2014) 0.97
Blood-brain barrier invasion by Cryptococcus neoformans is enhanced by functional interactions with plasmin. Microbiology (2011) 0.97
Breaking boundaries-coagulation and fibrinolysis at the neurovascular interface. Front Cell Neurosci (2015) 0.96
Towards retinoid therapy for Alzheimer's disease. Curr Alzheimer Res (2009) 0.92
Endogenous expression of matriptase in neural progenitor cells promotes cell migration and neuron differentiation. J Biol Chem (2010) 0.88
Phosphorylation of amyloid-β peptide at serine 8 attenuates its clearance via insulin-degrading and angiotensin-converting enzymes. J Biol Chem (2012) 0.88
Microglia and the urokinase plasminogen activator receptor/uPA system in innate brain inflammation. Glia (2009) 0.86
Metals affect the structure and activity of human plasminogen activator inhibitor-1. I. Modulation of stability and protease inhibition. Protein Sci (2011) 0.84
The emergence of proteinase-activated receptor-2 as a novel target for the treatment of inflammation-related CNS disorders. J Physiol (2007) 0.84
Association between neuroserpin and molecular markers of brain damage in patients with acute ischemic stroke. J Transl Med (2011) 0.83
The plasminogen activator system modulates sympathetic nerve function. J Exp Med (2006) 0.82
Tissue type plasminogen activator regulates myeloid-cell dependent neoangiogenesis during tissue regeneration. Blood (2010) 0.81
Effects of Korean Red Ginseng extract on tissue plasminogen activator and plasminogen activator inhibitor-1 expression in cultured rat primary astrocytes. J Ginseng Res (2013) 0.80
The voltage-dependent anion channel (VDAC) binds tissue-type plasminogen activator and promotes activation of plasminogen on the cell surface. J Biol Chem (2012) 0.79
Mechanisms of Aβ Clearance and Degradation by Glial Cells. Front Aging Neurosci (2016) 0.79
A chemical proteomic atlas of brain serine hydrolases identifies cell type-specific pathways regulating neuroinflammation. Elife (2016) 0.78
Decreased serotonin levels associated with behavioral disinhibition in tissue plasminogen activator deficient (tPA-/-) mice. Brain Res (2010) 0.77
Plasminogen Activator Inhibitor-1 in depression: Results from Animal and Clinical Studies. Sci Rep (2016) 0.77
Neuroprotective effect of neuroserpin in oxygen-glucose deprivation- and reoxygenation-treated rat astrocytes in vitro. PLoS One (2015) 0.76
Increased Serum PAI-1 Levels in Subjects with Metabolic Syndrome and Long-Term Adverse Mental Symptoms: A Population-Based Study. Cardiovasc Psychiatry Neurol (2010) 0.76
Engram formation in psychiatric disorders. Front Neurosci (2014) 0.76
Rapid Increases in proBDNF after Pilocarpine-Induced Status Epilepticus in Mice Are Associated with Reduced proBDNF Cleavage Machinery. eNeuro (2016) 0.75
Effect of Regulatory Element DNA Methylation on Tissue-Type Plasminogen Activator Gene Expression. PLoS One (2016) 0.75
Long-term potentiation--a decade of progress? Science (1999) 10.24
The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling. Nat Med (2001) 5.28
Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity. Science (2004) 4.74
Physiological consequences of loss of plasminogen activator gene function in mice. Nature (1994) 4.40
Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice. Nat Med (1998) 4.09
Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics. Annu Rev Pharmacol Toxicol (2002) 3.62
Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein. J Clin Invest (2003) 3.41
Tissue-plasminogen activator is induced as an immediate-early gene during seizure, kindling and long-term potentiation. Nature (1993) 3.23
Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator. Nat Med (2003) 3.10
Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator. Nature (1995) 3.06
Molecular mechanisms underlying emotional learning and memory in the lateral amygdala. Neuron (2004) 2.87
Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin. Cell (1997) 2.68
Tissue plasminogen activator neurovascular toxicity is controlled by activated protein C. Nat Med (2004) 2.45
Experience-dependent pruning of dendritic spines in visual cortex by tissue plasminogen activator. Neuron (2004) 2.40
An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. J Biol Chem (1994) 2.22
Tissue plasminogen activator contributes to the late phase of LTP and to synaptic growth in the hippocampal mossy fiber pathway. Neuron (1998) 2.13
Dendritic spine dynamics are regulated by monocular deprivation and extracellular matrix degradation. Neuron (2004) 2.12
Role of plasminogen system components in focal cerebral ischemic infarction: a gene targeting and gene transfer study in mice. Circulation (1999) 1.97
Neuroserpin reduces cerebral infarct volume and protects neurons from ischemia-induced apoptosis. Blood (2000) 1.90
Tissue plasminogen activator induction in Purkinje neurons after cerebellar motor learning. Science (1995) 1.84
Tissue plasminogen activator in the amygdala is critical for stress-induced anxiety-like behavior. Nat Neurosci (2003) 1.72
Role of tissue plasminogen activator receptor LRP in hippocampal long-term potentiation. J Neurosci (2000) 1.72
The tissue plasminogen activator-plasminogen proteolytic cascade accelerates amyloid-beta (Abeta) degradation and inhibits Abeta-induced neurodegeneration. J Neurosci (2003) 1.71
Tissue plasminogen activator mediates microglial activation via its finger domain through annexin II. J Neurosci (2002) 1.66
Enhanced hippocampal long-term potentiation and learning by increased neuronal expression of tissue-type plasminogen activator in transgenic mice. EMBO J (1999) 1.66
The plasmin system is induced by and degrades amyloid-beta aggregates. J Neurosci (2000) 1.62
Membrane depolarization induces calcium-dependent secretion of tissue plasminogen activator. J Neurosci (1996) 1.59
Permissive proteolytic activity for visual cortical plasticity. Proc Natl Acad Sci U S A (2002) 1.55
Spatial Memory and Learning in Transgenic Mice: Fact or Artifact? News Physiol Sci (1998) 1.54
The plasminogen (fibrinolytic) system. Thromb Haemost (1999) 1.54
Brain plasmin enhances APP alpha-cleavage and Abeta degradation and is reduced in Alzheimer's disease brains. EMBO Rep (2000) 1.49
Ethanol-withdrawal seizures are controlled by tissue plasminogen activator via modulation of NR2B-containing NMDA receptors. Proc Natl Acad Sci U S A (2005) 1.45
Regulation of seizure spreading by neuroserpin and tissue-type plasminogen activator is plasminogen-independent. J Clin Invest (2002) 1.44
Tissue plasminogen activator (t-PA) is targeted to the regulated secretory pathway. Catecholamine storage vesicles as a reservoir for the rapid release of t-PA. J Biol Chem (1997) 1.38
Neuroserpin, a neuroprotective factor in focal ischemic stroke. Mol Cell Neurosci (2001) 1.37
Rapid, activity-induced increase in tissue plasminogen activator is mediated by metabotropic glutamate receptor-dependent mRNA translation. J Neurosci (2004) 1.36
Neuronal cell death and tPA. Nature (1996) 1.33
Localization and regulation of the tissue plasminogen activator-plasmin system in the hippocampus. J Neurosci (2002) 1.31
Neuronal migration is retarded in mice lacking the tissue plasminogen activator gene. Proc Natl Acad Sci U S A (1999) 1.26
Neuronal death in the central nervous system demonstrates a non-fibrin substrate for plasmin. Proc Natl Acad Sci U S A (1997) 1.26
Tissue plasminogen activator mediates reverse occlusion plasticity in visual cortex. Nat Neurosci (1998) 1.19
Arginine 260 of the amino-terminal domain of NR1 subunit is critical for tissue-type plasminogen activator-mediated enhancement of N-methyl-D-aspartate receptor signaling. J Biol Chem (2004) 1.16
Tissue plasminogen activator promotes the effects of corticotropin-releasing factor on the amygdala and anxiety-like behavior. Proc Natl Acad Sci U S A (2004) 1.15
Plasmin cleavage of the amyloid beta-protein: alteration of secondary structure and stimulation of tissue plasminogen activator activity. Biochemistry (1999) 1.15
Tissue plasminogen activator and NMDA receptor cleavage. Nat Med (2003) 1.14
New functions for an old enzyme: nonhemostatic roles for tissue-type plasminogen activator in the central nervous system. Exp Biol Med (Maywood) (2004) 1.14
Absence of tissue plasminogen activator gene or activity impairs mouse cerebellar motor learning. J Neurosci (2003) 1.11
Laminin degradation by plasmin regulates long-term potentiation. J Neurosci (2000) 1.11
Impaired explorative behavior and neophobia in genetically modified mice lacking or overexpressing the extracellular serine protease inhibitor neuroserpin. Mol Cell Neurosci (2003) 1.11
Raft disorganization leads to reduced plasmin activity in Alzheimer's disease brains. EMBO Rep (2003) 1.09
Release of plasminogen activator and a calcium-dependent metalloprotease from cultured sympathetic and sensory neurons. Dev Biol (1985) 1.07
Rapid, specific and active site-catalyzed effect of tissue-plasminogen activator on hippocampus-dependent learning in mice. Neuroscience (2002) 1.07
Ham-Wasserman lecture: role of the plasminogen system in fibrin-homeostasis and tissue remodeling. Hematology Am Soc Hematol Educ Program (2001) 1.04
The tissue plasminogen activator-plasmin system participates in the rewarding effect of morphine by regulating dopamine release. Proc Natl Acad Sci U S A (2004) 1.00
Tissue plasminogen activator requires plasminogen to modulate amyloid-beta neurotoxicity and deposition. J Neurochem (2000) 1.00
Tissue plasminogen activator and neuroserpin are widely expressed in the human central nervous system. Thromb Haemost (2004) 0.97
Plasminogen activator inhibitor-1 in the cerebrospinal fluid as an index of neurological disease. Blood Coagul Fibrinolysis (1994) 0.93
The hippocampal laminin matrix is dynamic and critical for neuronal survival. Mol Biol Cell (2003) 0.92
Laminin chain expression suggests that laminin-10 is a major isoform in the mouse hippocampus and is degraded by the tissue plasminogen activator/plasmin protease cascade during excitotoxic injury. Neuroscience (2003) 0.90
Enhancement of mRNA expression of tissue-type plasminogen activator by L-threo-3,4-dihydroxyphenylserine in association with ocular dominance plasticity. Neurosci Lett (1996) 0.89
mRNAs encoding urokinase-type plasminogen activator and plasminogen activator inhibitor-1 are elevated in the mouse brain following kainate-mediated excitation. Brain Res Mol Brain Res (1997) 0.85
Hemostasis abnormalities in patients with vascular dementia and Alzheimer's disease. Thromb Haemost (1996) 0.80
Emotions are building up in the field of extracellular proteolysis. Trends Mol Med (2003) 0.79
Peripheral regeneration. Annu Rev Neurosci (2007) 2.94
Fibrinogen and beta-amyloid association alters thrombosis and fibrinolysis: a possible contributing factor to Alzheimer's disease. Neuron (2010) 2.37
Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease. J Exp Med (2007) 1.91
Laminin gamma1 is critical for Schwann cell differentiation, axon myelination, and regeneration in the peripheral nerve. J Cell Biol (2003) 1.78
Tissue plasminogen activator in the amygdala is critical for stress-induced anxiety-like behavior. Nat Neurosci (2003) 1.72
The tissue plasminogen activator-plasminogen proteolytic cascade accelerates amyloid-beta (Abeta) degradation and inhibits Abeta-induced neurodegeneration. J Neurosci (2003) 1.71
Aβ delays fibrin clot lysis by altering fibrin structure and attenuating plasminogen binding to fibrin. Blood (2012) 1.65
Tissue plasminogen activator and plasminogen mediate stress-induced decline of neuronal and cognitive functions in the mouse hippocampus. Proc Natl Acad Sci U S A (2005) 1.59
Schwann cell-specific ablation of laminin gamma1 causes apoptosis and prevents proliferation. J Neurosci (2005) 1.58
Fibrin depletion decreases inflammation and delays the onset of demyelination in a tumor necrosis factor transgenic mouse model for multiple sclerosis. Proc Natl Acad Sci U S A (2004) 1.54
Fibrin inhibits peripheral nerve remyelination by regulating Schwann cell differentiation. Neuron (2002) 1.48
Ethanol-withdrawal seizures are controlled by tissue plasminogen activator via modulation of NR2B-containing NMDA receptors. Proc Natl Acad Sci U S A (2005) 1.45
Localization and regulation of the tissue plasminogen activator-plasmin system in the hippocampus. J Neurosci (2002) 1.31
Key role of tissue plasminogen activator in neurovascular coupling. Proc Natl Acad Sci U S A (2008) 1.30
Both laminin and Schwann cell dystroglycan are necessary for proper clustering of sodium channels at nodes of Ranvier. J Neurosci (2005) 1.30
Alzheimer's disease peptide beta-amyloid interacts with fibrinogen and induces its oligomerization. Proc Natl Acad Sci U S A (2010) 1.28
Tissue plasminogen activator promotes the effects of corticotropin-releasing factor on the amygdala and anxiety-like behavior. Proc Natl Acad Sci U S A (2004) 1.15
Tissue plasminogen activator and NMDA receptor cleavage. Nat Med (2003) 1.14
Regulation of Schwann cell function by the extracellular matrix. Glia (2008) 1.14
Cortical deficiency of laminin gamma1 impairs the AKT/GSK-3beta signaling pathway and leads to defects in neurite outgrowth and neuronal migration. Dev Biol (2008) 1.08
Fibrinogen and altered hemostasis in Alzheimer's disease. J Alzheimers Dis (2012) 1.06
The APOE ɛ4/ɛ4 genotype potentiates vascular fibrin(ogen) deposition in amyloid-laden vessels in the brains of Alzheimer's disease patients. J Cereb Blood Flow Metab (2013) 1.01
Schwann cell myelination requires integration of laminin activities. J Cell Sci (2012) 1.00
Modulation of NR2B-regulated contextual fear in the hippocampus by the tissue plasminogen activator system. Proc Natl Acad Sci U S A (2007) 0.96
Laminin is required for Schwann cell morphogenesis. J Cell Sci (2009) 0.96
Fibrin is a regulator of Schwann cell migration after sciatic nerve injury in mice. Neurosci Lett (2003) 0.94
Ablation of astrocytic laminin impairs vascular smooth muscle cell function and leads to hemorrhagic stroke. J Cell Biol (2013) 0.93
Nervous system pathology: the fibrin perspective. Biol Chem (2002) 0.92
Maximum-entropy network analysis reveals a role for tumor necrosis factor in peripheral nerve development and function. Proc Natl Acad Sci U S A (2009) 0.92
Tissue plasminogen activator modulates the cellular and behavioral response to cocaine. Proc Natl Acad Sci U S A (2009) 0.92
Tissue plasminogen activator is required for the development of fetal alcohol syndrome in mice. Proc Natl Acad Sci U S A (2011) 0.92
The hippocampal laminin matrix is dynamic and critical for neuronal survival. Mol Biol Cell (2003) 0.92
Renal collecting system growth and function depend upon embryonic γ1 laminin expression. Development (2011) 0.90
Exogenous tissue plasminogen activator enhances peripheral nerve regeneration and functional recovery after injury in mice. J Neuropathol Exp Neurol (2006) 0.89
Mesenchymal stem cells facilitate axon sorting, myelination, and functional recovery in paralyzed mice deficient in Schwann cell-derived laminin. Glia (2011) 0.87
Plasmin-mediated degradation of laminin gamma-1 is critical for ethanol-induced neurodegeneration. Biol Psychiatry (2009) 0.87
Disruption of laminin in the peripheral nervous system impedes nonmyelinating Schwann cell development and impairs nociceptive sensory function. Glia (2009) 0.85
Tissue plasminogen activator and seizures: a clot-buster's secret life. J Clin Invest (2002) 0.83
The plasminogen activator system modulates sympathetic nerve function. J Exp Med (2006) 0.82
Disruption of tissue plasminogen activator gene reduces macrophage migration. Biochem Biophys Res Commun (2006) 0.82
Proteolytic fragments of laminin promote excitotoxic neurodegeneration by up-regulation of the KA1 subunit of the kainate receptor. J Cell Biol (2008) 0.82
The possible role of tissue-type plasminogen activator (tPA) and tPA blockers in the pathogenesis and treatment of Alzheimer's disease. J Mol Neurosci (2003) 0.79
The cellular origin of laminin determines its role in blood pressure regulation. Cell Mol Life Sci (2014) 0.77
Modulation of sympathetic activity by tissue plasminogen activator is independent of plasminogen and urokinase. J Pharmacol Exp Ther (2007) 0.76
Involvement of tissue plasminogen activator in stress responsivity during acute cocaine withdrawal in mice. Stress (2010) 0.75
Interactions of β-amyloid peptide with fibrinogen and coagulation factor XII may contribute to Alzheimer's disease. Curr Opin Hematol (2017) 0.75